Overview
- 4 inspections across 4 sites are on record.
- 6 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-05.
At a glance
Inspections
4
Sites
4
Observations
6
Career since
Jul 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Thermo Fisher Biopharma Services PTE. LTD | 5 May 2026 | Human Drugs | On file |
| DR. REDDY'S LABORATORIES LTD | 12 Oct 2023 | Human Drugs | On file |
| Patheon Pharmaceuticals Inc. | 15 Feb 2019 | Human Drugs | On file |
| Lilly del Caribe, Inc | 21 Jul 2017 | Human Drugs | On file |
Sites inspected
Thermo Fisher Biopharma Services PTE. LTDSingapore, Singapore1 insp.
DR. REDDY'S LABORATORIES LTDBachupally, India1 insp.
Patheon Pharmaceuticals Inc.Cincinnati, United States1 insp.
Lilly del Caribe, IncCarolina, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Madushini N Dharmasena2 shared
Lindsey S Fleischman1 shared
Jon P Antoniou1 shared
Lindsey M Schwierjohann1 shared
Rapti D Madurawe1 shared
Raquel Gonzalez Rivera1 shared
Krishna Ghosh1 shared
Noreen Muniz1 shared
Full investigator report
Get the verbatim findings behind Ying Zhang's 6 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site